CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 1169149-1169348 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Treatment with monoclonal antibodies (mAbs) to PD-1, especially during the effector phase, resulted in significant deterioration of the development of this disease both clinically and histologically.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T65187","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T65187","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T231","span":{"begin":0,"end":199},"obj":"Sentence"}],"attributes":[{"subj":"T231","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1167","span":{"begin":47,"end":49},"obj":"Disease"},{"id":"T8112","span":{"begin":47,"end":49},"obj":"Disease"}],"attributes":[{"id":"A1167","pred":"mondo_id","subj":"T1167","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"id":"A93848","pred":"mondo_id","subj":"T8112","obj":"http://purl.obolibrary.org/obo/MONDO_0005180"},{"subj":"T1167","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T8112","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93be","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93d8ec"},{"id":"CORD-19-PD-MONDO","color":"#ece693"}]}]}}